Literature DB >> 24789198

Improved molecular typing assay for rhinovirus species A, B, and C.

Yury A Bochkov1, Kristine Grindle2, Fue Vang2, Michael D Evans3, James E Gern4.   

Abstract

Human rhinoviruses (RVs), comprising three species (A, B, and C) of the genus Enterovirus, are responsible for the majority of upper respiratory tract infections and are associated with severe lower respiratory tract illnesses such as pneumonia and asthma exacerbations. High genetic diversity and continuous identification of new types necessitate regular updating of the diagnostic assays for the accurate and comprehensive detection of circulating RVs. Methods for molecular typing based on phylogenetic comparisons of a variable fragment in the 5' untranslated region were improved to increase assay sensitivity and to eliminate nonspecific amplification of human sequences, which are observed occasionally in clinical samples. A modified set of primers based on new sequence information and improved buffers and enzymes for seminested PCR assays provided higher specificity and sensitivity for virus detection. In addition, new diagnostic primers were designed for unequivocal species and type assignments for RV-C isolates, based on phylogenetic analysis of partial VP4/VP2 coding sequences. The improved assay was evaluated by typing RVs in >3,800 clinical samples. RVs were successfully detected and typed in 99% of the samples that were RV positive in multiplex diagnostic assays.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789198      PMCID: PMC4097758          DOI: 10.1128/JCM.00075-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Mfold web server for nucleic acid folding and hybridization prediction.

Authors:  Michael Zuker
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Estimation of errors in "raw" DNA sequences: a validation study.

Authors:  P Richterich
Journal:  Genome Res       Date:  1998-03       Impact factor: 9.043

3.  A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100.

Authors:  V V Hamparian; R J Colonno; M K Cooney; E C Dick; J M Gwaltney; J H Hughes; W S Jordan; A Z Kapikian; W J Mogabgab; A Monto
Journal:  Virology       Date:  1987-07       Impact factor: 3.616

4.  Evidence for at least two dominant neutralization antigens on human rhinovirus 14.

Authors:  B Sherry; R Rueckert
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses.

Authors:  Pia Laine; Carita Savolainen; Soile Blomqvist; Tapani Hovi
Journal:  J Gen Virol       Date:  2005-03       Impact factor: 3.891

6.  Phylogenetic analysis of rhinovirus isolates collected during successive epidemic seasons.

Authors:  Carita Savolainen; Mick N Mulders; Tapani Hovi
Journal:  Virus Res       Date:  2002-04-23       Impact factor: 3.303

7.  Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction.

Authors:  R E Gama; P R Horsnell; P J Hughes; C North; C B Bruce; W al-Nakib; G Stanway
Journal:  J Med Virol       Date:  1989-06       Impact factor: 2.327

8.  VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.

Authors:  Rebecca M Ledford; Nitesh R Patel; Tina M Demenczuk; Adiba Watanyar; Torsten Herbertz; Marc S Collett; Daniel C Pevear
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types.

Authors:  Chloe L McIntyre; Nick J Knowles; Peter Simmonds
Journal:  J Gen Virol       Date:  2013-05-15       Impact factor: 3.891

10.  Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays.

Authors:  M T Coiras; J C Aguilar; M L García; I Casas; P Pérez-Breña
Journal:  J Med Virol       Date:  2004-03       Impact factor: 2.327

View more
  47 in total

1.  Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze.

Authors:  Kohei Hasegawa; Jonathan M Mansbach; Yury A Bochkov; James E Gern; Pedro A Piedra; Cindy S Bauer; Stephen J Teach; Susan Wu; Ashley F Sullivan; Carlos A Camargo
Journal:  JAMA Pediatr       Date:  2019-06-01       Impact factor: 16.193

Review 2.  Lessons learned from birth cohort studies conducted in diverse environments.

Authors:  Daniel J Jackson; James E Gern; Robert F Lemanske
Journal:  J Allergy Clin Immunol       Date:  2017-02       Impact factor: 10.793

3.  Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.

Authors:  Stephen J Teach; Michelle A Gill; Alkis Togias; Christine A Sorkness; Samuel J Arbes; Agustin Calatroni; Jeremy J Wildfire; Peter J Gergen; Robyn T Cohen; Jacqueline A Pongracic; Carolyn M Kercsmar; Gurjit K Khurana Hershey; Rebecca S Gruchalla; Andrew H Liu; Edward M Zoratti; Meyer Kattan; Kristine A Grindle; James E Gern; William W Busse; Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2015-10-27       Impact factor: 10.793

4.  Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma.

Authors:  Kathryn McCauley; Juliana Durack; Ricardo Valladares; Douglas W Fadrosh; Din L Lin; Agustin Calatroni; Petra K LeBeau; Hoang T Tran; Kei E Fujimura; Brandon LaMere; Geil Merana; Kole Lynch; Robyn T Cohen; Jacqueline Pongracic; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Michelle Gill; Andrew H Liu; Haejin Kim; Meyer Kattan; Stephen J Teach; Alkis Togias; Homer A Boushey; James E Gern; Daniel J Jackson; Susan V Lynch
Journal:  J Allergy Clin Immunol       Date:  2019-06-13       Impact factor: 10.793

5.  Superiority of Digital Reverse Transcription-PCR (RT-PCR) over Real-Time RT-PCR for Quantitation of Highly Divergent Human Rhinoviruses.

Authors:  Ruth Hall Sedlak; Thuy Nguyen; Isabel Palileo; Keith R Jerome; Jane Kuypers
Journal:  J Clin Microbiol       Date:  2016-11-23       Impact factor: 5.948

6.  Recurrent rhinovirus detections in children following a rhinovirus-induced wheezing exacerbation: A retrospective study.

Authors:  Sofie Halmø Hürdum; Guicheng Zhang; Siew-Kim Khoo; Joelene Bizzintino; Kimberley Marie Franks; Katie Lindsay; Anthony David Keil; Desmond William Cox; Jack Goldblatt; Yury Alexandrovich Bochkov; James Gern; Charlotte Suppli Ulrik; Peter Neils Le Souëf; Ingrid Alisa Laing
Journal:  Int J Pediatr Child Health       Date:  2015-08

7.  Rhinovirus is the most common virus and rhinovirus-C is the most common species in paediatric intensive care respiratory admissions.

Authors:  Desmond W Cox; Siew-Kim Khoo; Guicheng Zhang; Katie Lindsay; Anthony D Keil; Geoff Knight; James E Gern; Ingrid A Laing; Joelene Bizzintino; Peter N Le Souëf
Journal:  Eur Respir J       Date:  2018-08-09       Impact factor: 16.671

Review 8.  Microbes, allergic sensitization, and the natural history of asthma.

Authors:  Halie M Anderson; Daniel J Jackson
Journal:  Curr Opin Allergy Clin Immunol       Date:  2017-04

9.  Respiratory viruses are associated with serum metabolome among infants hospitalized for bronchiolitis: A multicenter study.

Authors:  Michimasa Fujiogi; Carlos A Camargo; Yoshihiko Raita; Yury A Bochkov; James E Gern; Jonathan M Mansbach; Pedro A Piedra; Kohei Hasegawa
Journal:  Pediatr Allergy Immunol       Date:  2020-06-10       Impact factor: 6.377

10.  Association of rhinovirus species with common cold and asthma symptoms and bacterial pathogens.

Authors:  Hiba Bashir; Kristine Grindle; Rose Vrtis; Fue Vang; Teresa Kang; Lisa Salazar; Elizabeth Anderson; Tressa Pappas; Ronald Gangnon; Michael D Evans; Daniel J Jackson; Robert F Lemanske; Yury A Bochkov; James E Gern
Journal:  J Allergy Clin Immunol       Date:  2017-10-27       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.